Pascal Laforêt

1.0k citations

18 papers · 367 indexed · h-index 9

Impact in

Genetics top 10%
- Neurogenetic and Muscular Disorders Research
Rheumatology top 10%
- Glycogen Storage Diseases and Myoclonus

Papers in ⓘ

Molecular Biology 10
- Muscle Physiology and Disorders 4
Physiology 8
- Lysosomal Storage Disorders Research 7

Co-authors: Kristl G. Claeys (7 shared papers)B. Eymard (4 shared papers)N. Pellegrini (1 shared paper)Frédéric Lofaso (1 shared paper)B. Eymard (1 shared paper)Catherine Caillaud (1 shared paper)Mariangela Pellegrini (1 shared paper)Norma B. Romero (3 shared papers)
Journals: Neuromuscular Disorders (5 papers)Muscle & Nerve (2 papers)PLoS ONE (2 papers)Journal of Inherited Metabolic Disease (1 paper)Acta Neuropathologica (1 paper)
Partner nations: France United States United Kingdom

In The Last Decade

Pascal Laforêt

18 papers receiving 361 citations

Peers

Countries citing papers authored by Pascal Laforêt

Since Specialization

Citations

This map shows the geographic impact of Pascal Laforêt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Laforêt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Laforêt more than expected).

Fields of papers citing papers by Pascal Laforêt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Laforêt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Laforêt. The network helps show where Pascal Laforêt may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Laforêt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Laforêt Line = papers co-authored together Pascal Laforêt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	“Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy Acta Neuropathologica ·Jorge A. Bevilacqua, Marc Bitoun, Valérie Biancalana, Anders Oldfors, G. Stoltenburg, Kristl G. Claeys, Emmanuelle Lacène, Guy Brochier, Linda Manéré, Pascal Laforêt, B. Eymard, Pascale Guicheney, Michel Fardeau, Norma B. Romero	2008	85
2	Respiratory insufficiency and limb muscle weakness in adults with Pompe’s disease European Respiratory Journal ·N. Pellegrini, Pascal Laforêt, D. Orlikowski, Mariangela Pellegrini, Catherine Caillaud, B. Eymard, J-C. Raphael, Frédéric Lofaso	2005	84
3	Progress and challenges of gene therapy for Pompe disease Annals of Translational Medicine ·Giuseppe Ronzitti, Fanny Collaud, Pascal Laforêt, Federico Mingozzi	2019	35
4	Adult cases of mitochondrial DNA depletion due to TK2 defect Neurology ·Anthony Béhin, Claude Jardel, Kristl G. Claeys, Jérôme Fagart, Malek Louha, Norma B. Romero, Pascal Laforêt, B. Eymard, Anne Lombès	2012	35
5	Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy Neuromuscular Disorders ·Claire Wary, Aleksandra Nadaj‐Pakleza, Pascal Laforêt, Kristl G. Claeys, Robert Carlier, A. Monnet, Servanne Fleury, Céline Baligand, B. Eymard, Philippe Labrune, Pierre G. Carlier	2010	31
6	Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA PLoS ONE ·Mohamed‐Mounir El Mendili, Timothée Lenglet, Tanya Stojkovic, Anthony Béhin, Raquel Guimarães‐Costa, François Salachas, Vincent Meininger, Gaëlle Bruneteau, Nadine Le Forestier, Pascal Laforêt, Stéphane Lehéricy, Habib Benali, Pierre‐François Pradat	2016	23
7	Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study Journal of Neurology ·Giorgia Querin, Timothée Lenglet, Rabab Debs, Tanya Stojkovic, Anthony Béhin, François Salachas, Nadine Le Forestier, Maria del Mar Amador, Gaëlle Bruneteau, Pascal Laforêt, Sophie Blancho, Véronique Marchand‐Pauvert, Peter Bede, Jean‐Yves Hogrel, Pierre-François Pradat	2021	21
8	DNAJB2 Expression in Normal and Diseased Human and Mouse Skeletal Muscle American Journal Of Pathology ·Kristl G. Claeys, M. Sozanska, Jean‐Jacques Martin, Emmanuelle Lacène, L Vignaud, Daniel Stockholm, Pascal Laforêt, B. Eymard, Antoine Kichler, Daniel Scherman, Thomas Voit, David Israeli	2010	18
9	Acute but transient neurological deterioration revealing adult polyglucosan body disease Journal of the Neurological Sciences ·S. Billot, Dominique Hervé, Hasan O. Akman, Roseline Froissart, Christiane Baussan, Kristl G. Claeys, Monique Piraud, Frédéric Sedel, Fanny Mochel, Pascal Laforêt	2012	12
10	Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study Revue Neurologique ·Claire Lefeuvre, M. Brisset, M. Sarlon, Núria Mestres Petit, David Orlikowski, Bernard Clair, T. Thiry, RY Carlier, Hélène Prigent, Gaël Nicolas, Djillali Annane, Pascal Laforêt, Samuel Pouplin	2022	7
11	Whole‐Body Muscle Magnetic Resonance Imaging in Glycogen‐Storage Disease Type III Muscle & Nerve ·David Tobaly, Pascal Laforêt, Ariane Perry, Dalila Habès, Philippe Labrune, V. Decostre, Marion Masingue, François Petit, Andrea Barp, Luca Bello, Pierre G. Carlier, Robert‐Yves Carlier	2019	6
12	Identification of wheelchair seating criteria in adults with neuromuscular diseases: A Delphi study PLoS ONE ·Élise Dupitier, M. Voisin, Caroline Stalens, Pascal Laforêt, Samuel Pouplin	2023	2
13	Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders Journal of Inherited Metabolic Disease ·Apolline Imbard, Hortense de Calbiac, Édouard Le Guillou, Pascal Laforêt, Manuel Schiff, Anaïs Brassier, Eugénie Thevenet, Clément Pontoizeau, Bertrand Lefrère, Chris Ottolenghi, Élise Lebigot, Pauline Gaignard, Stéphanie Gobin, Cécile Acquaviva, Jean‐François Benoist, Caroline Tuchmann‐Durand, Antoine Legendre, Pascale de Lonlay	2024	2
14	G.P.1.02 Phenotypic spectrum of core-rod myopathy caused by dominant or recessive RYR1 mutations Neuromuscular Disorders ·Kristl G. Claeys, Nicole Monnier, Pascal Laforêt, Guy Brochier, Ana Ferreiro, A Barois, B. Eymard, Joël Lunardi, Michel Fardeau, Norma B. Romero	2009	2
15	Exploration of muscle metabolism during exercise and muscle imaging in late-onset form of multiple acyl-coA dehydrogenase deficiency (MADD) Neuromuscular Disorders ·Sarah Souvannanorath, Stéphane Hatem, M.H. Becquemin, N. Zraik, Roseli Saraiva Moreira Bittar, Odile Rigal, R. Carlier, Pierre G. Carlier, Pascal Laforêt	2015	1
16	G.P.1 01 Clinical presentation and disease progression in late-onset Pompe disease Neuromuscular Disorders ·Diana M. Escolar, John H. J. Wokke, Alan Pestronk, G.T. Carter, Kenneth M. Jaffe, Pascal Laforêt	2006	1
17	Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL Muscle & Nerve ·Hani Kushlaf, Jordi Díaz‐Manera, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Paula R. Clemens, Mazen M. Dimachkie, Priya S. Kishnani, Pascal Laforêt, Mark Roberts, Benedikt Schoser, António Toscano, Jeff Castelli, Fred Holdbrook, Sheela Sitaraman Das, Mitchell H. Goldman, Tahseen Mozaffar, (unknown)	2025	1
18	Adeno associated vector-based gene therapy strategy for type 3 glycogen storage disease Neuromuscular Disorders ·Pierre Vidal, Giuseppe Ronzitti, Fanny Collaud, Marcelo Simon Sola, P. Collela, Francesco Puzzo, Helena Costa Verdera, Séverine Charles, Alban Vignaud, Laetitia van Wittenberghe, Bernard Gjata, Monika Gjorgjieva, Pascal Laforêt, Fabienne Rajas, Edoardo Malfatti, Gıancarlo Comı, Federico Mingozzi	2017	1

About Pascal Laforêt

Pascal Laforêt is a scholar working on Molecular Biology, Physiology, Genetics, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 367 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (7 papers), Neurogenetic and Muscular Disorders Research (6 papers), Glycogen Storage Diseases and Myoclonus (6 papers), Muscle Physiology and Disorders (4 papers), Metabolism and Genetic Disorders (3 papers), Child Nutrition and Feeding Issues (2 papers), Congenital Anomalies and Fetal Surgery (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). The work is most often cited by research in Genetics (85 citations), Rheumatology (118 citations), Physiology (133 citations), Clinical Biochemistry (32 citations) and Cell Biology (50 citations). Pascal Laforêt has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Kristl G. Claeys, B. Eymard, N. Pellegrini, Frédéric Lofaso, B. Eymard, Catherine Caillaud, Mariangela Pellegrini, Norma B. Romero, Giuseppe Ronzitti and Fanny Collaud. Their work appears in journals such as Neuromuscular Disorders, Muscle & Nerve, PLoS ONE, Journal of Inherited Metabolic Disease and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact